Quantitative disability evaluation of syndromes presenting with chronic fatigue

South African Medical Journal

Volumn 90, Issue 10 II, 2000, Pages 1034-1052

  Coetzer, P ^a   Lockyer, I ^a   Schorn, D ^a   Boshoff, L ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMITRIPTYLINE; ANALGESIC AGENT; CODEINE; CYANOCOBALAMIN; FLUOXETINE; FOLIC ACID; IMMUNOGLOBULIN; LIVER EXTRACT; NONSTEROID ANTIINFLAMMATORY AGENT; OXYGEN; SEROTONIN UPTAKE INHIBITOR; TRAZODONE; TRICYCLIC ANTIDEPRESSANT AGENT;

ANAMNESIS; ARTICLE; CHRONIC FATIGUE SYNDROME; CLINICAL PROTOCOL; CONTROLLED STUDY; DAILY LIFE ACTIVITY; DIAGNOSTIC TEST; DISABILITY; DISEASE PREDISPOSITION; EMPLOYMENT; ENERGY; EVALUATION; FIBROMYALGIA; FUNCTIONAL ASSESSMENT; FUNCTIONAL DISEASE; HUMAN; LABORATORY TEST; MEDICAL RECORD; MENTAL HEALTH; OXYGEN CONSUMPTION; PAIN ASSESSMENT; PHYSICAL EXAMINATION; PHYSIOTHERAPY; PROGNOSIS; RISK FACTOR; SYMPTOMATOLOGY; VIRUS INFECTION; WORKLOAD;

DISABILITY EVALUATION; DOCUMENTATION; FATIGUE SYNDROME, CHRONIC; FIBROMYALGIA; HUMANS; PAIN MEASUREMENT; PRACTICE GUIDELINES; QUESTIONNAIRES; REPRODUCIBILITY OF RESULTS; SOUTH AFRICA;

EID: 0033766901     PISSN: 02569574     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Somatization and medicalization in era of managed health care
2. The chronic mononucleosis syndrome
3. Chronic fatigue syndrome: An update
4. Chronic fatigue syndrome: A working case definition
5. Chronic fatigue syndrome and occupational health
6. Chronic fatigue syndrome and fibromyalgia
7. Current Medical Diagnosis and Treatment
8. Chronic fatigue syndrome: Clinical condition associated with immune activation
9. Immunologic abnormalities associated with chronic fatigue syndrome
10. The differential diagnosis of generalised pain
11. The American College of Rheumatology 1990 criteria for the classification of fibromyalgia. Report of the Multi Centre Criteria Committee
12. Myofascial pain
13. Is fibromyalgia a distinct clinical entity? Historical and epidemiological evidence
14. The occurence and impact of generalised pain
15. The pain-prone disorder: A clinical and physiological profile
16. Vergleichende test psychologische untersuchungen bei verschiedenen rheumatischen erkrankungen und der hypertonie
17. The prevalence and characteristics of fibromyalgia in the general population
18. Treatment options for regional musculoskeletal pain: What is the evidence?
19. Multi disciplinary group programmes to treat fibromyalgia patients
20. Drug therapy
21. The effect of Zolphiden on patients with fibromyalgia, a dose ranging double blind, placebo controlled modified cross over study
22. Efficacy of Ultralam (tramadol HCl) in the treatment of fibromyalgia syndrome: Preliminary analysis of a multi-center randomized, placebo-controlled study
23. Population study of tender point counts and pain as evidence of fibromyalgia
24. The prevalence and characteristics of fibromyalgia in the general population
25. Comparison between self-report measures and clinical observations of functional disability in ankylosing spondilitis, rheumatoid arthritis and fibromialgia
26. The fibromyalgia impact questionnaire: Development and validation
27. Nonorganic physical signs in low-back pain